FDA is speeding up review time for approval to just 6

Quote:

Novartis ($NVS) was given another boost today... after the FDA said it will now speed up its work on reviewing the med.....

Specifically, its candidate has been given the FDA sped-up priority review......

This lowers the time the FDA takes to come to a decision on a med from 10 months after filing to six months .